Schultze JL - Search Results

1

Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.

Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL. Xue J, et al. Among authors: schultze jl. Immunity. 2014 Feb 20;40(2):274-88. doi: 10.1016/j.immuni.2014.01.006. Epub 2014 Feb 13. Immunity. 2014. PMID: 24530056 Free PMC article.

2

Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.

Chemnitz JM, Driesen J, Classen S, Riley JL, Debey S, Beyer M, Popov A, Zander T, Schultze JL. Chemnitz JM, et al. Among authors: schultze jl. Cancer Res. 2006 Jan 15;66(2):1114-22. doi: 10.1158/0008-5472.CAN-05-3252. Cancer Res. 2006. PMID: 16424048

3

Regulatory T cells in cancer.

Beyer M, Schultze JL. Beyer M, et al. Among authors: schultze jl. Blood. 2006 Aug 1;108(3):804-11. doi: 10.1182/blood-2006-02-002774. Blood. 2006. PMID: 16861339 Free article. Review.

4

Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.

Classen S, Zander T, Eggle D, Chemnitz JM, Brors B, Büchmann I, Popov A, Beyer M, Eils R, Debey S, Schultze JL. Classen S, et al. Among authors: schultze jl. J Immunol. 2007 Jun 1;178(11):6931-40. doi: 10.4049/jimmunol.178.11.6931. J Immunol. 2007. PMID: 17513742

5

CD4+CD25highFOXP3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype.

Beyer M, Schultze JL. Beyer M, et al. Among authors: schultze jl. J Clin Oncol. 2007 Jun 20;25(18):2628-30; author reply 2630-2. doi: 10.1200/JCO.2006.08.0192. J Clin Oncol. 2007. PMID: 17577047 No abstract available.

6

RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma.

Chemnitz JM, Eggle D, Driesen J, Classen S, Riley JL, Debey-Pascher S, Beyer M, Popov A, Zander T, Schultze JL. Chemnitz JM, et al. Among authors: schultze jl. Blood. 2007 Nov 1;110(9):3226-33. doi: 10.1182/blood-2006-12-064360. Epub 2007 Jul 20. Blood. 2007. PMID: 17644739 Free article.

7

Immunoregulatory T cells: role and potential as a target in malignancy.

Beyer M, Schultze JL. Beyer M, et al. Among authors: schultze jl. Curr Oncol Rep. 2008 Mar;10(2):130-6. doi: 10.1007/s11912-008-0021-z. Curr Oncol Rep. 2008. PMID: 18377826 Review.

8

Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms.

Popov A, Driesen J, Abdullah Z, Wickenhauser C, Beyer M, Debey-Pascher S, Saric T, Kummer S, Takikawa O, Domann E, Chakraborty T, Krönke M, Utermöhlen O, Schultze JL. Popov A, et al. Among authors: schultze jl. J Immunol. 2008 Oct 1;181(7):4976-88. doi: 10.4049/jimmunol.181.7.4976. J Immunol. 2008. PMID: 18802101

9

Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy".

Beyer M, Karbach J, Mallmann MR, Zander T, Eggle D, Classen S, Debey-Pascher S, Famulok M, Jäger E, Schultze JL. Beyer M, et al. Among authors: schultze jl. Cancer Res. 2009 May 15;69(10):4346-54. doi: 10.1158/0008-5472.CAN-08-3796. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435912 Free article.

10

Regulatory T cells: major players in the tumor microenvironment.

Beyer M, Schultze JL. Beyer M, et al. Among authors: schultze jl. Curr Pharm Des. 2009;15(16):1879-92. doi: 10.2174/138161209788453211. Curr Pharm Des. 2009. PMID: 19519430 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page